STAAR Surgical | STAA - Selling And Administration Expenses

Stock Price
32.08
Daily Change
0.07 0.22%
Monthly
30.30%
Yearly
66.91%
Q2 Forecast
26.14

STAAR Surgical reported $38.64M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Bausch Health Companies USD 813M 12M Mar/2026
Boston Scientific USD 1.78B 53M Mar/2026
Cerus USD 19.33M 1.55M Dec/2024
Cooper Companies USD 373.1M 46.1M Dec/2025
J&J USD 6.03B 719M Mar/2026
Merit Medical Systems USD 110.47M 4.36M Mar/2026
Novartis USD 3.14B 296M Mar/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Orthofix International USD 130.35M 11.31M Dec/2025
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 38.64M 299K Mar/2026
Utah Medical Products USD 2.61M 741K Dec/2025